Somatostatin Receptor Imaging in Cardiac Sarcoidosis
NCT02812849 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2020-10-14
Summary
The purpose of the trial is to determine the accuracy of Cu-64 labelled DOTATATE for diagnosing cardiac sarcoidosis using PET/CT or PET/MRI.
Conditions
- Cardiac Sarcoidosis
Interventions
- DRUG
-
Cu-64 DOTATATE
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Rasmus S Ripa, MD, DMSc · Rigshospitalet, Denmark
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2019-11-30
- Completion
- 2020-02-27
Countries
- Denmark
Study Locations
More Related Trials
-
Cardiac Sarcoidosis and FDG-PET
NCT00958087 ·Status: COMPLETED
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Wegener's Granulomatosis With Cyclophosphamide
NCT00001155 ·Status: COMPLETED ·Phase: PHASE2
-
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rituximab in Eosinophilic Granulomatosis With Polyangiitis
NCT02807103 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Diagnostic and Prognostic Role of SAA in Intrathoracic Sarcoidosis
NCT05811962 ·Status: COMPLETED
-
Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
NCT05749666 ·Status: UNKNOWN ·Phase: PHASE3
-
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
NCT05230693 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
NCT02994927 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis
NCT03324503 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3
-
Development of a Novel Human In Vitro Sarcoidosis Model
NCT01857401 ·Status: COMPLETED
-
CASPA: CArdiac Sarcoidosis in PApworth
NCT03599414 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
NCT03192969 ·Status: WITHDRAWN ·Phase: PHASE3
-
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
NCT02457585 ·Status: UNKNOWN ·Phase: PHASE2
-
Cardiac Sarcoidosis Response To Steroids Trial
NCT01210677 ·Status: WITHDRAWN ·Phase: PHASE4
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Tofacitinib in Treating ANCA-associated Vasculitis
NCT04973033 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
NCT02888080 ·Status: COMPLETED ·Phase: PHASE2
-
Neurosarcoidosis : Initial Presentation and Disease Course
NCT04911348 ·Status: UNKNOWN
-
Low-dose Glucocorticoid Vasculitis Induction Study
NCT02198248 ·Status: UNKNOWN ·Phase: PHASE4